| 1 |
Low ABCB1 gene expression is an early event in colorectal carcinogenesis.PLoS One. 2013 Aug 19;8(8):e72119. doi: 10.1371/journal.pone.0072119. eCollection 2013.
|
| 2 |
Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.Gastroenterology. 2004 Mar;126(3):654-9. doi: 10.1053/j.gastro.2004.01.008.
|
| 3 |
Adenosine kinase gene expression in human colorectal cancer.Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):750-4. doi: 10.1080/15257770802145629.
|
| 4 |
Polymorphisms of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 and colorectal cancer risk in Chinese males.World J Gastroenterol. 2008 Aug 28;14(32):5078-83. doi: 10.3748/wjg.14.5078.
|
| 5 |
AMACR expression in colorectal cancer is associated with left-sided tumor localization.Virchows Arch. 2008 Sep;453(3):243-8. doi: 10.1007/s00428-008-0646-1. Epub 2008 Aug 19.
|
| 6 |
Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res. 2008 Apr 15;68(8):2803-12.
|
| 7 |
Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.Mol Ther. 2014 May;22(5):1018-28. doi: 10.1038/mt.2014.41. Epub 2014 Mar 6.
|
| 8 |
An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.Hum Gene Ther. 2017 Aug;28(8):667-680. doi: 10.1089/hum.2017.033.
|
| 9 |
Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia.Carcinogenesis. 2011 Feb;32(2):203-9. doi: 10.1093/carcin/bgq237. Epub 2010 Nov 16.
|
| 10 |
Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.Int J Oncol. 2008 Sep;33(3):573-7.
|
| 11 |
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors.Cancer Res. 2014 Nov 15;74(22):6693-704. doi: 10.1158/0008-5472.CAN-14-1331. Epub 2014 Sep 19.
|
| 12 |
Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors.Cancer Sci. 2009 Mar;100(3):405-12. doi: 10.1111/j.1349-7006.2008.01052.x. Epub 2008 Dec 24.
|
| 13 |
Altered expression of KCNK9 in colorectal cancers.APMIS. 2004 Sep;112(9):588-94. doi: 10.1111/j.1600-0463.2004.apm1120905.x.
|
| 14 |
(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem Biol Interact. 2010 May 14;185(3):247-52. doi: 10.1016/j.cbi.2010.03.036. Epub 2010 Mar 25.
|
| 15 |
Microsomal glutathione S-transferase gene polymorphisms and colorectal cancer risk in a Han Chinese population.Int J Colorectal Dis. 2007 Oct;22(10):1185-94. doi: 10.1007/s00384-007-0308-9. Epub 2007 May 5.
|
| 16 |
Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.BMC Cancer. 2008 Nov 17;8:337. doi: 10.1186/1471-2407-8-337.
|
| 17 |
Genome-wide association study of colorectal cancer in Hispanics.Carcinogenesis. 2016 Jun;37(6):547-556. doi: 10.1093/carcin/bgw046. Epub 2016 Apr 18.
|
| 18 |
Variance in the expression of 5-Fluorouracil pathway genes in colorectal cancer.Clin Cancer Res. 2005 Apr 1;11(7):2612-9. doi: 10.1158/1078-0432.CCR-04-1258.
|
| 19 |
Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer.Gastroenterology. 2011 Dec;141(6):2039-46. doi: 10.1053/j.gastro.2011.08.041. Epub 2011 Sep 3.
|
| 20 |
Transcription factor PDX-1 in human colorectal adenocarcinoma: a potential tumor marker?.World J Gastroenterol. 2008 Oct 14;14(38):5823-6. doi: 10.3748/wjg.14.5823.
|
| 21 |
Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors.Transl Oncol. 2019 Mar;12(3):404-416. doi: 10.1016/j.tranon.2018.11.009. Epub 2018 Dec 14.
|
| 22 |
Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells.Int J Mol Med. 2007 Sep;20(3):405-9.
|
| 23 |
Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer.Oncol Rep. 2006 Jun;15(6):1437-43.
|
| 24 |
Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer.J Cell Mol Med. 2008 Oct;12(5B):1936-43. doi: 10.1111/j.1582-4934.2008.00253.x. Epub 2008 Feb 4.
|
| 25 |
Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans.Biochim Biophys Acta. 2005 Jun 30;1741(1-2):215-23. doi: 10.1016/j.bbadis.2005.04.002.
|
| 26 |
Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer.Int J Cancer. 2007 Nov 15;121(10):2192-7. doi: 10.1002/ijc.22953.
|
| 27 |
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.Gastroenterology. 2019 Apr;156(5):1455-1466. doi: 10.1053/j.gastro.2018.11.066. Epub 2018 Dec 6.
|
| 28 |
Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer.PLoS One. 2010 Sep 27;5(9):e13027. doi: 10.1371/journal.pone.0013027.
|
| 29 |
Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma.PLoS One. 2011;6(12):e27399. doi: 10.1371/journal.pone.0027399. Epub 2011 Dec 13.
|
| 30 |
Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.Int J Oncol. 2007 Jan;30(1):91-5.
|
| 31 |
The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk.Am J Clin Nutr. 2007 Sep;86(3):743-51. doi: 10.1093/ajcn/86.3.743.
|
| 32 |
Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54. doi: 10.1158/1055-9965.EPI-07-2947.
|
| 33 |
Genomic and epigenomic integration identifies a prognostic signature in colon cancer.Clin Cancer Res. 2011 Mar 15;17(6):1535-45. doi: 10.1158/1078-0432.CCR-10-2509. Epub 2011 Jan 28.
|
| 34 |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.J Mol Diagn. 2014 Nov;16(6):660-72. doi: 10.1016/j.jmoldx.2014.06.004. Epub 2014 Aug 23.
|
| 35 |
Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression.Hum Pathol. 2015 Mar;46(3):411-8. doi: 10.1016/j.humpath.2014.11.016. Epub 2014 Dec 10.
|
| 36 |
Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor gene therapy combined with thermotherapy.J Cancer Res Clin Oncol. 2014 Apr;140(4):623-32. doi: 10.1007/s00432-014-1611-9. Epub 2014 Feb 15.
|
| 37 |
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.Nat Genet. 2013 Mar;45(3):253-61. doi: 10.1038/ng.2538. Epub 2013 Jan 27.
|
| 38 |
Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.Gastroenterology. 2020 Feb;158(3):638-651.e8. doi: 10.1053/j.gastro.2019.10.009. Epub 2019 Oct 14.
|
| 39 |
Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target.Future Oncol. 2009 May;5(4):509-22. doi: 10.2217/fon.09.14.
|
| 40 |
The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy.Mol Cancer Ther. 2017 Oct;16(10):2223-2233. doi: 10.1158/1535-7163.MCT-17-0336. Epub 2017 Jul 20.
|
| 41 |
Highly sensitive MLH1 methylation analysis in blood identifies a cancer patient with low-level mosaic MLH1 epimutation.Clin Epigenetics. 2019 Nov 28;11(1):171. doi: 10.1186/s13148-019-0762-6.
|
| 42 |
Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial.Mol Carcinog. 2019 Apr;58(4):511-523. doi: 10.1002/mc.22945. Epub 2018 Dec 21.
|
| 43 |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.
|
| 44 |
Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.Cancer Lett. 2017 Jan 28;385:21-27. doi: 10.1016/j.canlet.2016.11.002. Epub 2016 Nov 9.
|
| 45 |
Risks of colorectal neoplasms and cardiovascular thromboembolic events after the combined use of selective COX-2 inhibitors and aspirin with 5-year follow-up: a meta-analysis.Colorectal Dis. 2019 Apr;21(4):417-426. doi: 10.1111/codi.14556. Epub 2019 Feb 7.
|
| 46 |
Proteomic analysis of intestinal epithelial cells expressing stabilized beta-catenin.Cancer Res. 2003 Aug 1;63(15):4641-7.
|
| 47 |
The role of ABC transporters in progression and clinical outcome of colorectal cancer.Mutagenesis. 2012 Mar;27(2):187-96. doi: 10.1093/mutage/ger075.
|
| 48 |
ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.Tumour Biol. 2016 Sep;37(9):12889-12896. doi: 10.1007/s13277-016-5209-5. Epub 2016 Jul 23.
|
| 49 |
Mutation and LOH analysis of ACO2 in colorectal cancer: no evidence of biallelic genetic inactivation.J Med Genet. 2003 May;40(5):e73. doi: 10.1136/jmg.40.5.e73.
|
| 50 |
Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells.Clin Cancer Res. 2004 Sep 1;10(17):5895-901. doi: 10.1158/1078-0432.CCR-1134-03.
|
| 51 |
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer.Carcinogenesis. 2007 Jun;28(6):1197-201. doi: 10.1093/carcin/bgl242. Epub 2006 Dec 6.
|
| 52 |
Overexpression of 15-lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells.Mol Cancer Res. 2005 Sep;3(9):511-7. doi: 10.1158/1541-7786.MCR-05-0011.
|
| 53 |
The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3).Mol Cancer Ther. 2005 May;4(5):693-703. doi: 10.1158/1535-7163.MCT-04-0337.
|
| 54 |
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.Int J Cancer. 2009 Jun 15;124(12):2905-10. doi: 10.1002/ijc.24273.
|
| 55 |
Novel Common Genetic Susceptibility Loci for Colorectal Cancer.J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.
|
| 56 |
BAGE hypomethylation, a new epigenetic biomarker for colon cancer detection.Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1374-9. doi: 10.1158/1055-9965.EPI-07-2656. Epub 2008 Jun 9.
|
| 57 |
Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.Clin Cancer Res. 2014 Jul 1;20(13):3472-84. doi: 10.1158/1078-0432.CCR-13-2944. Epub 2014 Apr 24.
|
| 58 |
ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.World J Gastroenterol. 2006 Sep 28;12(36):5884-9. doi: 10.3748/wjg.v12.i36.5884.
|
| 59 |
Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients.PLoS One. 2018 Dec 17;13(12):e0208762. doi: 10.1371/journal.pone.0208762. eCollection 2018.
|
| 60 |
Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer.Mol Cancer. 2015 Jul 2;14:126. doi: 10.1186/s12943-015-0397-y.
|
| 61 |
T-cell responses to survivin in cancer patients undergoing radiation therapy.Clin Cancer Res. 2008 Aug 1;14(15):4883-90. doi: 10.1158/1078-0432.CCR-07-4462.
|
| 62 |
Discovery of common and rare genetic risk variants for colorectal cancer.Nat Genet. 2019 Jan;51(1):76-87. doi: 10.1038/s41588-018-0286-6. Epub 2018 Dec 3.
|
| 63 |
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.Cancer Res. 2016 Sep 1;76(17):5103-14. doi: 10.1158/0008-5472.CAN-15-2980. Epub 2016 Apr 20.
|
| 64 |
Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.Cancer Res. 2002 Jan 1;62(1):13-7.
|
| 65 |
Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa.World J Gastroenterol. 2005 May 7;11(17):2616-25. doi: 10.3748/wjg.v11.i17.2616.
|
| 66 |
Calreticulin exposure dictates the immunogenicity of cancer cell death.Nat Med. 2007 Jan;13(1):54-61. doi: 10.1038/nm1523. Epub 2006 Dec 24.
|
| 67 |
Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.APMIS. 2006 Sep;114(9):646-50. doi: 10.1111/j.1600-0463.2006.apm_417.x.
|
| 68 |
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.Nat Genet. 2007 May;39(5):605-13. doi: 10.1038/ng2030. Epub 2007 Apr 22.
|
| 69 |
15-hydroxyprostaglandin dehydrogenase in colorectal mucosa as a potential biomarker for predicting colorectal neoplasms.J Korean Med Sci. 2013 Aug;28(8):1154-60. doi: 10.3346/jkms.2013.28.8.1154. Epub 2013 Jul 31.
|
| 70 |
Relationship of TGF-1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis.APMIS. 2013 Oct;121(10):967-75. doi: 10.1111/apm.12096. Epub 2013 Sep 2.
|
| 71 |
Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.J Immunol. 2008 Mar 1;180(5):3347-56. doi: 10.4049/jimmunol.180.5.3347.
|
| 72 |
Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.Int J Oncol. 2015 Apr;46(4):1582-8. doi: 10.3892/ijo.2015.2844. Epub 2015 Jan 23.
|
| 73 |
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.Cancer Immunol Immunother. 2003 Oct;52(10):638-42. doi: 10.1007/s00262-003-0402-y. Epub 2003 Jun 14.
|
| 74 |
Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma.Lab Invest. 2001 Apr;81(4):465-73. doi: 10.1038/labinvest.3780254.
|
| 75 |
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.PLoS Med. 2008 May 27;5(5):e114. doi: 10.1371/journal.pmed.0050114.
|
| 76 |
Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma.Cancer. 2004 Apr 15;100(8):1615-21. doi: 10.1002/cncr.20172.
|
| 77 |
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.Clin Cancer Res. 2008 Jun 15;14(12):3798-806. doi: 10.1158/1078-0432.CCR-07-5103.
|
| 78 |
T cell immunity induced by a bivalent Salmonella-based CEACAM6 and 4-1BBL vaccines in a rat colorectal cancer model.Oncol Lett. 2017 May;13(5):3753-3759. doi: 10.3892/ol.2017.5938. Epub 2017 Mar 28.
|
| 79 |
Pharmacogenomic assessment of carboxylesterases 1 and 2.Genomics. 2004 Oct;84(4):661-8. doi: 10.1016/j.ygeno.2004.07.008.
|
| 80 |
c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.Histopathology. 2007 Aug;51(2):150-6. doi: 10.1111/j.1365-2559.2007.02723.x. Epub 2007 Jun 8.
|
| 81 |
Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.Int J Cancer. 2002 Oct 20;101(6):545-8. doi: 10.1002/ijc.90009.
|
| 82 |
Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.Int J Cancer. 2019 Nov 15;145(10):2682-2691. doi: 10.1002/ijc.32304. Epub 2019 Apr 15.
|
| 83 |
Combined 5-FU and ChoK inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.PLoS One. 2013 Jun 10;8(6):e64961. doi: 10.1371/journal.pone.0064961. Print 2013.
|
| 84 |
Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells.Br J Cancer. 2003 May 19;88(10):1598-604. doi: 10.1038/sj.bjc.6600927.
|
| 85 |
Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer.Clin Biochem. 2008 Oct;41(14-15):1224-36. doi: 10.1016/j.clinbiochem.2008.07.012. Epub 2008 Jul 30.
|
| 86 |
The expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location.Neoplasma. 2018 Nov 15;65(6):986-992. doi: 10.4149/neo_2018_180122N47. Epub 2018 Jun 18.
|
| 87 |
CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.Am J Surg. 2013 Sep;206(3):418-27. doi: 10.1016/j.amjsurg.2012.11.021. Epub 2013 Jun 24.
|
| 88 |
Down-regulation of the tumor suppressor gene C-terminal Src kinase: an early event during premalignant colonic epithelial hyperproliferation.FEBS Lett. 2005 Jul 4;579(17):3497-502. doi: 10.1016/j.febslet.2005.05.030.
|
| 89 |
Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer.Int J Biol Markers. 2004 Oct-Dec;19(4):289-94. doi: 10.1177/172460080401900406.
|
| 90 |
A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.Sci Rep. 2015 May 20;5:10442. doi: 10.1038/srep10442.
|
| 91 |
Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.Gastroenterology. 2016 Jun;150(7):1633-1645. doi: 10.1053/j.gastro.2016.02.076. Epub 2016 Mar 8.
|
| 92 |
Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population.Oncol Rep. 2010 Nov;24(5):1347-53. doi: 10.3892/or_00000992.
|
| 93 |
Overexpression of CYP2A6 in human colorectal tumors.Cancer Sci. 2007 Oct;98(10):1582-5. doi: 10.1111/j.1349-7006.2007.00572.x. Epub 2007 Aug 7.
|
| 94 |
The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese.Clin Chim Acta. 2007 May 1;380(1-2):191-6. doi: 10.1016/j.cca.2007.02.033. Epub 2007 Feb 22.
|
| 95 |
A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.Lab Invest. 2017 Oct;97(10):1245-1261. doi: 10.1038/labinvest.2017.40. Epub 2017 Apr 17.
|
| 96 |
Clinical significance of Smac/DIABLO expression in colorectal cancer.Oncol Rep. 2009 Feb;21(2):351-5.
|
| 97 |
The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.Oncogene. 2014 Apr 24;33(17):2157-68. doi: 10.1038/onc.2013.178. Epub 2013 May 27.
|
| 98 |
Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma.Cancer Lett. 2004 Jun 8;209(1):67-74. doi: 10.1016/j.canlet.2003.11.033.
|
| 99 |
Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.Proteomics. 2008 Jan;8(2):316-32. doi: 10.1002/pmic.200700819.
|
| 100 |
Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients.J Cancer Res Clin Oncol. 2013 Apr;139(4):691-702. doi: 10.1007/s00432-013-1372-x. Epub 2013 Jan 16.
|
| 101 |
Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.Hum Pathol. 2008 Jan;39(1):80-6. doi: 10.1016/j.humpath.2007.05.011. Epub 2007 Oct 18.
|
| 102 |
Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.Int J Oncol. 2009 Jan;34(1):53-60.
|
| 103 |
Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival. Br J Cancer. 2009 Apr 7;100(7):1095-102. doi: 10.1038/sj.bjc.6604970. Epub 2009 Mar 10.
|
| 104 |
Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.PLoS One. 2018 Dec 17;13(12):e0208080. doi: 10.1371/journal.pone.0208080. eCollection 2018.
|
| 105 |
KSR1 and EPHB4 Regulate Myc and PGC1 To Promote Survival of Human Colon Tumors.Mol Cell Biol. 2016 Aug 12;36(17):2246-61. doi: 10.1128/MCB.00087-16. Print 2016 Sep 1.
|
| 106 |
'Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer'.Cancer Lett. 2005 Sep 28;227(2):229-36. doi: 10.1016/j.canlet.2004.06.030.
|
| 107 |
A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.J Biol Chem. 2006 Mar 31;281(13):8829-35. doi: 10.1074/jbc.M507331200. Epub 2006 Feb 2.
|
| 108 |
Developments in the study of gastrointestinal microbiome disorders affected by FGF19 in the occurrence and development of colorectal neoplasms.J Cell Physiol. 2020 May;235(5):4060-4069. doi: 10.1002/jcp.29322. Epub 2019 Oct 21.
|
| 109 |
Keratinocyte growth factor-transfection-stimulated adhesion of colorectal cancer cells to extracellular matrices.Exp Mol Pathol. 2007 Dec;83(3):443-52. doi: 10.1016/j.yexmp.2007.07.001. Epub 2007 Jul 24.
|
| 110 |
Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.Oncol Rep. 2008 Jan;19(1):41-7.
|
| 111 |
MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism.PLoS One. 2014 Oct 1;9(10):e108708. doi: 10.1371/journal.pone.0108708. eCollection 2014.
|
| 112 |
Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.J Org Chem. 2001 Aug 24;66(17):5655-63. doi: 10.1021/jo005757n.
|
| 113 |
Frizzled-7 as a potential therapeutic target in colorectal cancer.Neoplasia. 2008 Jul;10(7):697-705. doi: 10.1593/neo.08320.
|
| 114 |
Genome-wide diet-gene interaction analyses for risk of colorectal cancer.PLoS Genet. 2014 Apr 17;10(4):e1004228. doi: 10.1371/journal.pgen.1004228. eCollection 2014 Apr.
|
| 115 |
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.Clin Cancer Res. 2009 Jun 15;15(12):3990-7. doi: 10.1158/1078-0432.CCR-09-0055. Epub 2009 Jun 9.
|
| 116 |
Low expression of gamma-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype.Br J Cancer. 2008 May 6;98(9):1555-61. doi: 10.1038/sj.bjc.6604346. Epub 2008 Apr 15.
|
| 117 |
DNA methylation analyses of the connexin gene family reveal silencing of GJC1 (Connexin45) by promoter hypermethylation in colorectal cancer.Epigenetics. 2011 May;6(5):602-9. doi: 10.4161/epi.6.5.15237. Epub 2011 May 1.
|
| 118 |
HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.PLoS One. 2010 Apr 29;5(4):e10338. doi: 10.1371/journal.pone.0010338.
|
| 119 |
The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth.Oncogene. 2008 Mar 27;27(14):2045-54. doi: 10.1038/sj.onc.1210842. Epub 2007 Oct 8.
|
| 120 |
Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.Cancer Res. 2011 May 1;71(9):3341-51. doi: 10.1158/0008-5472.CAN-10-3473. Epub 2011 Mar 17.
|
| 121 |
OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.Gastroenterology. 2016 Mar;150(3):659-671.e16. doi: 10.1053/j.gastro.2015.11.041. Epub 2015 Nov 24.
|
| 122 |
Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression.BMC Cancer. 2011 May 24;11:195:1-11. doi: 10.1186/1471-2407-11-195.
|
| 123 |
Expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer.Cancer Lett. 2004 Jul 8;210(1):95-100. doi: 10.1016/j.canlet.2003.12.019.
|
| 124 |
Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling.Proteomics. 2006 Apr;6(8):2600-8. doi: 10.1002/pmic.200500427.
|
| 125 |
Overexpression of Id-1 protein is a marker in colorectal cancer progression.Oncol Rep. 2008 Feb;19(2):419-24.
|
| 126 |
5-Fluorouracil-interferon-alpha 2b adjuvant treatment of Dukes C colorectal cancer.Dis Colon Rectum. 1994 Jul;37(7):643-50. doi: 10.1007/BF02054406.
|
| 127 |
High-Yield Methylation Markers for Stool-Based Detection of Colorectal Cancer.Dig Dis Sci. 2020 Jun;65(6):1710-1719. doi: 10.1007/s10620-019-05908-9. Epub 2019 Nov 12.
|
| 128 |
KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer.Tumour Biol. 2013 Feb;34(1):471-9. doi: 10.1007/s13277-012-0572-3. Epub 2012 Nov 7.
|
| 129 |
Dynamic down-regulation of Krppel-like factor 4 in colorectal adenoma-carcinoma sequence.J Cancer Res Clin Oncol. 2008 Aug;134(8):891-8. doi: 10.1007/s00432-008-0353-y. Epub 2008 Feb 9.
|
| 130 |
NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting.Clin Cancer Res. 2009 Nov 15;15(22):6993-7002. doi: 10.1158/1078-0432.CCR-09-0991. Epub 2009 Oct 27.
|
| 131 |
L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.Ann Surg Oncol. 2007 May;14(5):1703-11. doi: 10.1245/s10434-006-9281-8. Epub 2007 Jan 9.
|
| 132 |
Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells.Pathol Int. 2004 Sep;54(9):688-92. doi: 10.1111/j.1440-1827.2004.01681.x.
|
| 133 |
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.Clin Cancer Res. 2005 Mar 15;11(6):2293-9. doi: 10.1158/1078-0432.CCR-04-1642.
|
| 134 |
Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression. Carcinogenesis. 2014 Dec;35(12):2778-86. doi: 10.1093/carcin/bgu209. Epub 2014 Oct 3.
|
| 135 |
Oncogenic KRAS signalling promotes the Wnt/-catenin pathway through LRP6 in colorectal cancer.Oncogene. 2015 Sep 17;34(38):4914-27. doi: 10.1038/onc.2014.416. Epub 2014 Dec 15.
|
| 136 |
Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.Int J Colorectal Dis. 2008 Jan;23(1):29-35. doi: 10.1007/s00384-007-0373-0. Epub 2007 Aug 18.
|
| 137 |
Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer.Hum Immunol. 2008 Jul;69(7):414-20. doi: 10.1016/j.humimm.2008.05.005. Epub 2008 Jun 11.
|
| 138 |
Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance.Int J Oncol. 2008 Aug;33(2):245-51.
|
| 139 |
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis.Pharmacol Res. 2017 May;119:227-236. doi: 10.1016/j.phrs.2017.02.002. Epub 2017 Feb 11.
|
| 140 |
O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer.Carcinogenesis. 2013 Nov;34(11):2435-42. doi: 10.1093/carcin/bgt275. Epub 2013 Aug 8.
|
| 141 |
Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses.J Biol Chem. 2013 May 17;288(20):14647-14656. doi: 10.1074/jbc.M112.439893. Epub 2013 Apr 2.
|
| 142 |
Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.J Surg Res. 2008 May 1;146(1):32-42. doi: 10.1016/j.jss.2007.02.011. Epub 2007 May 31.
|
| 143 |
Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.Cell Biochem Funct. 2007 Jul-Aug;25(4):433-41. doi: 10.1002/cbf.1325.
|
| 144 |
MicroRNA-1271 suppresses the proliferation and invasion of colorectal cancer cells by regulating metadherin/Wnt signaling.J Biochem Mol Toxicol. 2018 Feb;32(2). doi: 10.1002/jbt.22028. Epub 2018 Jan 5.
|
| 145 |
Dietary B vitamin and methionine intake and MTHFR C677T genotype on risk of colorectal tumors in Lynch syndrome: the GEOLynch cohort study.Cancer Causes Control. 2014 Sep;25(9):1119-29. doi: 10.1007/s10552-014-0412-4. Epub 2014 Jun 12.
|
| 146 |
Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.Carcinogenesis. 2009 Aug;30(8):1452-8. doi: 10.1093/carcin/bgp137. Epub 2009 Jun 11.
|
| 147 |
The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.Int J Cancer. 2016 Mar 15;138(6):1472-81. doi: 10.1002/ijc.29891. Epub 2015 Oct 30.
|
| 148 |
Role of MYH polymorphisms in sporadic colorectal cancer in China: a case-control, population-based study.Asian Pac J Cancer Prev. 2013;14(11):6403-9. doi: 10.7314/apjcp.2013.14.11.6403.
|
| 149 |
Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells.PLoS One. 2013 Jul 29;8(7):e69963. doi: 10.1371/journal.pone.0069963. Print 2013.
|
| 150 |
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.J Clin Invest. 2018 Jun 1;128(6):2325-2338. doi: 10.1172/JCI96711. Epub 2018 Apr 30.
|
| 151 |
Tomato powder impedes the development of azoxymethane-induced colorectal cancer in rats through suppression of COX-2 expression via NF-B and regulating Nrf2/HO-1 pathway.Mol Nutr Food Res. 2012 Sep;56(9):1477-81. doi: 10.1002/mnfr.201200130. Epub 2012 Aug 1.
|
| 152 |
Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2.Nutr Cancer. 2017 Feb-Mar;69(2):276-288. doi: 10.1080/01635581.2017.1263346. Epub 2017 Jan 3.
|
| 153 |
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer.Oncol Res. 2007;16(11):535-48. doi: 10.3727/096504007783438376.
|
| 154 |
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.Asian Pac J Cancer Prev. 2010;11(1):209-13.
|
| 155 |
PPAR agonist enhances colitis-associated colorectal cancer.Eur J Pharmacol. 2019 Jan 5;842:248-254. doi: 10.1016/j.ejphar.2018.10.050. Epub 2018 Nov 2.
|
| 156 |
Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer.J Biol Chem. 2006 Feb 3;281(5):2676-82. doi: 10.1074/jbc.M507752200. Epub 2005 Nov 17.
|
| 157 |
Colon cancer cells produce immunoregulatory glucocorticoids.Oncogene. 2011 May 26;30(21):2411-9. doi: 10.1038/onc.2010.629. Epub 2011 Jan 24.
|
| 158 |
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.J Natl Cancer Inst. 2008 Jan 16;100(2):109-20. doi: 10.1093/jnci/djm279. Epub 2008 Jan 8.
|
| 159 |
Integrated Analysis of the Endoscopic, Pathological and Molecular Characteristics of Colorectal Tumorigenesis.Digestion. 2019;99(1):33-38. doi: 10.1159/000494410. Epub 2018 Dec 14.
|
| 160 |
Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress.Cancer Discov. 2018 May;8(5):632-647. doi: 10.1158/2159-8290.CD-17-0533. Epub 2018 Mar 2.
|
| 161 |
Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.Cancer Prev Res (Phila). 2011 Dec;4(12):2072-82. doi: 10.1158/1940-6207.CAPR-11-0300. Epub 2011 Sep 19.
|
| 162 |
A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.Mol Cell Proteomics. 2011 Dec;10(12):M111.009712. doi: 10.1074/mcp.M111.009712. Epub 2011 Oct 10.
|
| 163 |
Significant overexpression of oligophrenin-1 in colorectal tumors detected by cDNA microarray analysis. Cancer Lett. 2001 Oct 22;172(1):67-73.
|
| 164 |
PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression.Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4061-E4070. doi: 10.1073/pnas.1712345115. Epub 2018 Apr 9.
|
| 165 |
Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.Gastroenterology. 2007 Jul;133(1):219-31. doi: 10.1053/j.gastro.2007.04.048. Epub 2007 Apr 25.
|
| 166 |
Modulation of expression of Programmed Death-1 by administration of probiotic Dahi in DMH-induced colorectal carcinogenesis in rats.Acta Biomed. 2013 Sep 1;84(2):102-9.
|
| 167 |
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.Am J Gastroenterol. 2005 Oct;100(10):2280-7. doi: 10.1111/j.1572-0241.2005.00223.x.
|
| 168 |
Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability.J Clin Pathol. 2008 Apr;61(4):524-9. doi: 10.1136/jcp.2007.046987.
|
| 169 |
Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.Cancer Res. 2007 Oct 15;67(20):9721-30. doi: 10.1158/0008-5472.CAN-07-2735.
|
| 170 |
Pim-2 Modulates Aerobic Glycolysis and Energy Production during the Development of Colorectal Tumors.Int J Med Sci. 2015 Jun 8;12(6):487-93. doi: 10.7150/ijms.10982. eCollection 2015.
|
| 171 |
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.J Clin Invest. 2016 Feb;126(2):681-94. doi: 10.1172/JCI83587. Epub 2016 Jan 19.
|
| 172 |
Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.Oncogene. 1998 Oct 15;17(15):2009-12. doi: 10.1038/sj.onc.1202121.
|
| 173 |
Antigen levels of urokinase-type plasminogen activator receptor and its gene polymorphism related to microvessel density in colorectal cancer.Acta Biochim Pol. 2008;55(2):357-63. Epub 2008 May 29.
|
| 174 |
NF-kappaB and Hsp70 are involved in the phospholipase Cgamma1 signaling pathway in colorectal cancer cells.Life Sci. 2005 Oct 14;77(22):2794-803. doi: 10.1016/j.lfs.2005.05.025.
|
| 175 |
Requirement of phospholipase D1 activity in H-RasV12-induced transformation.Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1638-42. doi: 10.1073/pnas.0406698102. Epub 2005 Jan 24.
|
| 176 |
Expression of phospholipase D2 in human colorectal carcinoma.Oncol Rep. 2007 Nov;18(5):1329-34.
|
| 177 |
Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.Hum Genet. 1999 Jul-Aug;105(1-2):79-85. doi: 10.1007/s004399900064.
|
| 178 |
Human POLB gene is mutated in high percentage of colorectal tumors.J Biol Chem. 2012 Jul 6;287(28):23830-9. doi: 10.1074/jbc.M111.324947. Epub 2012 May 10.
|
| 179 |
Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis. 2005 May;26(5):908-15. doi: 10.1093/carcin/bgi034. Epub 2005 Feb 24.
|
| 180 |
Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation.J Biol Chem. 2006 May 26;281(21):14700-10. doi: 10.1074/jbc.M602623200. Epub 2006 Mar 30.
|
| 181 |
PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations.Hum Mol Genet. 2007 Apr 15;16(8):993-1005. doi: 10.1093/hmg/ddm045. Epub 2007 Mar 6.
|
| 182 |
Overexpression in colorectal carcinoma of two lysosomal enzymes, CLN2 and CLN1, involved in neuronal ceroid lipofuscinosis.Cancer. 2006 Apr 1;106(7):1489-97. doi: 10.1002/cncr.21764.
|
| 183 |
Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.Anticancer Res. 1996 Nov-Dec;16(6B):3459-66.
|
| 184 |
Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int J Cancer. 1995 Mar 29;61(1):35-9. doi: 10.1002/ijc.2910610107.
|
| 185 |
Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells.Clin Exp Metastasis. 2016 Jun;33(5):441-51. doi: 10.1007/s10585-016-9788-8. Epub 2016 Apr 25.
|
| 186 |
Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.Tissue Antigens. 2004 May;63(5):446-52. doi: 10.1111/j.0001-2815.2004.00204.x.
|
| 187 |
Instability of a dinucleotide repeat in the 3'-untranslated region (UTR) of the microsomal prostaglandin E synthase-1 (mPGES-1) gene in microsatellite instability-high (MSI-H) colorectal carcinoma.Mol Oncol. 2015 Aug;9(7):1252-8. doi: 10.1016/j.molonc.2015.01.009. Epub 2015 Mar 5.
|
| 188 |
A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.FASEB J. 2018 Oct;32(10):5661-5673. doi: 10.1096/fj.201701446R. Epub 2018 May 10.
|
| 189 |
Mutational analysis of FLASH and PTPN13 genes in colorectal carcinomas.Pathology. 2008 Jan;40(1):31-4. doi: 10.1080/00313020701716441.
|
| 190 |
The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer.Dig Dis Sci. 2008 Feb;53(2):467-73. doi: 10.1007/s10620-007-9887-0. Epub 2007 Jun 28.
|
| 191 |
Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis.Oncology. 2007;72(5-6):371-80. doi: 10.1159/000113147. Epub 2008 Jan 14.
|
| 192 |
RET fusions observed in lung and colorectal cancers are sensitive to ponatinib.Oncotarget. 2018 Jul 3;9(51):29654-29664. doi: 10.18632/oncotarget.25664. eCollection 2018 Jul 3.
|
| 193 |
RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer.Oncol Lett. 2017 Aug;14(2):2281-2287. doi: 10.3892/ol.2017.6412. Epub 2017 Jun 19.
|
| 194 |
RNF6 Promotes Colorectal Cancer by Activating the Wnt/-Catenin Pathway via Ubiquitination of TLE3.Cancer Res. 2018 Apr 15;78(8):1958-1971. doi: 10.1158/0008-5472.CAN-17-2683. Epub 2018 Jan 26.
|
| 195 |
RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.Sci Rep. 2017 Nov 10;7(1):15270. doi: 10.1038/s41598-017-15704-y.
|
| 196 |
RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.Anticancer Res. 2010 Jul;30(7):2673-82.
|
| 197 |
Sensitivity of neoplastic cells to senescence unveiled under standard cell culture conditions.Anticancer Res. 2015 May;35(5):2759-68.
|
| 198 |
Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma.PLoS One. 2017 Mar 28;12(3):e0174343. doi: 10.1371/journal.pone.0174343. eCollection 2017.
|
| 199 |
Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer.Int J Cancer. 2006 May 1;118(9):2247-54. doi: 10.1002/ijc.21620.
|
| 200 |
[The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].Zhonghua Yi Xue Za Zhi. 2007 Jul 24;87(28):1954-7.
|
| 201 |
Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer.Gut. 2009 Feb;58(2):249-60. doi: 10.1136/gut.2008.149468. Epub 2008 Jul 17.
|
| 202 |
Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).Tumour Biol. 2016 Sep;37(9):12231-12239. doi: 10.1007/s13277-016-5066-2. Epub 2016 May 28.
|
| 203 |
The reduced folate carrier (RFC1) 80G > A and folate hydrolase 1 (FOLH1) 1561C > T polymorphisms and the risk of colorectal cancer: a nested case-referent study.Scand J Clin Lab Invest. 2008;68(5):393-401. doi: 10.1080/00365510701805431.
|
| 204 |
Associations of single nucleotide polymorphisms with mucinous colorectal cancer: genome-wide common variant and gene-based rare variant analyses.Biomark Res. 2018 Jun 13;6:17. doi: 10.1186/s40364-018-0133-z. eCollection 2018.
|
| 205 |
Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population.Gut. 2011 Jun;60(6):799-805. doi: 10.1136/gut.2010.215947. Epub 2011 Jan 17.
|
| 206 |
Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.Biol Pharm Bull. 2018;41(3):445-449. doi: 10.1248/bpb.b17-00743.
|
| 207 |
Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease.Cancer Sci. 2008 Oct;99(10):1924-32. doi: 10.1111/j.1349-7006.2008.00947.x.
|
| 208 |
Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.Mol Cell Proteomics. 2014 May;13(5):1198-218. doi: 10.1074/mcp.M113.035105. Epub 2014 Feb 24.
|
| 209 |
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.Br J Cancer. 2008 Jun 3;98(11):1810-9. doi: 10.1038/sj.bjc.6604377. Epub 2008 May 6.
|
| 210 |
SPDEF functions as a colorectal tumor suppressor by inhibiting -catenin activity.Gastroenterology. 2013 May;144(5):1012-1023.e6. doi: 10.1053/j.gastro.2013.01.043. Epub 2013 Feb 1.
|
| 211 |
Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab.Cancer Res. 2007 Sep 1;67(17):8240-7. doi: 10.1158/0008-5472.CAN-07-0589.
|
| 212 |
Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa.Clin Cancer Res. 2002 Feb;8(2):419-27.
|
| 213 |
The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.BMC Cancer. 2006 Jul 4;6:176. doi: 10.1186/1471-2407-6-176.
|
| 214 |
Overexpression of serine-threonine receptor kinase-associated protein in colorectal cancers.Pathol Int. 2007 Apr;57(4):178-82. doi: 10.1111/j.1440-1827.2007.02078.x.
|
| 215 |
Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition. BMC Cancer. 2006 Oct 9;6:243. doi: 10.1186/1471-2407-6-243.
|
| 216 |
Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.Oncogene. 1994 Jan;9(1):291-8.
|
| 217 |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.Sci Rep. 2015 Dec 1;5:17369. doi: 10.1038/srep17369.
|
| 218 |
Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors.Int J Biol Markers. 2003 Oct-Dec;18(4):301-10. doi: 10.1177/172460080301800409.
|
| 219 |
Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer.Cancer Lett. 2006 Jul 18;238(2):188-96. doi: 10.1016/j.canlet.2005.07.001. Epub 2005 Aug 18.
|
| 220 |
Thrombopoietin and reticulated platelets as thrombopoietic markers in colorectal cancer.Thromb Res. 2008;122(1):141-3. doi: 10.1016/j.thromres.2007.10.003. Epub 2007 Dec 3.
|
| 221 |
Identification of potential genes/proteins regulated by Tiam1 in colorectal cancer by microarray analysis and proteome analysis.Cell Biol Int. 2008 Oct;32(10):1215-22. doi: 10.1016/j.cellbi.2008.07.004. Epub 2008 Jul 16.
|
| 222 |
Absence of fusion of TMPRSS2 and ETS transcription factor genes in gastric and colorectal carcinomas.APMIS. 2007 Mar;115(3):252-3. doi: 10.1111/j.1600-0463.2007.apm_652.x.
|
| 223 |
Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma.Oncogene. 2004 Aug 26;23(39):6666-71. doi: 10.1038/sj.onc.1207888.
|
| 224 |
Assessment expression of the adhesion molecules, CD134 and CD137, in patients with colorectal cancer by flow cytometry.Rocz Akad Med Bialymst. 2004;49 Suppl 1:34-6.
|
| 225 |
Expression of CD137 and CD137 ligand in colorectal cancer patients.Oncol Rep. 2006 May;15(5):1197-200.
|
| 226 |
Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Int J Oncol. 2007 Mar;30(3):679-87.
|
| 227 |
[Expression of APRIL in colorectal carcinoma tissues and effects of chemotherapeutic agents on APRIL expression in colorectal carcinoma SW480 cells]. Ai Zheng. 2008 Apr;27(4):369-73.
|
| 228 |
A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.Cancer Res. 2013 May 15;73(10):3132-44. doi: 10.1158/0008-5472.CAN-12-4562. Epub 2013 Mar 28.
|
| 229 |
Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?.Am J Cancer Res. 2017 Feb 1;7(2):370-382. eCollection 2017.
|
| 230 |
Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis.Cancer Lett. 2009 Apr 18;276(2):228-38. doi: 10.1016/j.canlet.2008.11.018. Epub 2008 Dec 25.
|
| 231 |
TREM-1 promotes intestinal tumorigenesis.Sci Rep. 2017 Nov 1;7(1):14870. doi: 10.1038/s41598-017-14516-4.
|
| 232 |
Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells.Oncol Rep. 2017 Oct;38(4):2480-2488. doi: 10.3892/or.2017.5896. Epub 2017 Aug 10.
|
| 233 |
TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells.Mol Oncol. 2019 Nov;13(11):2393-2405. doi: 10.1002/1878-0261.12566. Epub 2019 Sep 12.
|
| 234 |
Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease.Anticancer Res. 2002 Nov-Dec;22(6C):4045-8.
|
| 235 |
Progesterone receptor positive colorectal tumors have lower thymidine phosphorylase expression: an immunohistochemical study.Pak J Biol Sci. 2007 Dec 15;10(24):4485-9. doi: 10.3923/pjbs.2007.4485.4489.
|
| 236 |
Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.Clin Cancer Res. 2015 Aug 15;21(16):3695-704. doi: 10.1158/1078-0432.CCR-14-2457. Epub 2015 May 5.
|
| 237 |
PGP9.5 methylation as a marker for metastatic colorectal cancer.Anticancer Res. 2008 Sep-Oct;28(5A):2697-700.
|
| 238 |
Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan.Oncol Rep. 2007 Mar;17(3):637-45.
|
| 239 |
Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer.Pharmacogenomics J. 2013 Apr;13(2):148-58. doi: 10.1038/tpj.2011.65. Epub 2012 Jan 17.
|
| 240 |
USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol. 2017 May 1;131:29-39.
|
| 241 |
The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression.J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):106-9. doi: 10.1016/j.jsbmb.2010.01.014. Epub 2010 Feb 6.
|
| 242 |
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.Gastroenterology. 2015 Jun;148(7):1438-51.e8. doi: 10.1053/j.gastro.2015.03.005. Epub 2015 Mar 6.
|
| 243 |
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8822-7. doi: 10.1073/pnas.0600645103. Epub 2006 May 24.
|
| 244 |
Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells.Neoplasia. 2007 Sep;9(9):745-54. doi: 10.1593/neo.07442.
|
| 245 |
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer.Fam Cancer. 2010 Jun;9(2):125-9. doi: 10.1007/s10689-009-9293-1.
|
| 246 |
Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.Nat Genet. 2014 Jun;46(6):533-42. doi: 10.1038/ng.2985. Epub 2014 May 18.
|
| 247 |
Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.Tumour Biol. 2014 May;35(5):4673-85. doi: 10.1007/s13277-014-1612-y. Epub 2014 Jan 16.
|
| 248 |
Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population.BMC Cancer. 2008 Nov 3;8:317. doi: 10.1186/1471-2407-8-317.
|
| 249 |
Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.World J Gastroenterol. 2006 Sep 21;12(35):5651-7. doi: 10.3748/wjg.v12.i35.5651.
|
| 250 |
Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China.Cancer Lett. 2009 Mar 8;275(1):102-8. doi: 10.1016/j.canlet.2008.10.017. Epub 2008 Nov 25.
|
| 251 |
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.Virchows Arch. 2008 Feb;452(2):139-46. doi: 10.1007/s00428-007-0558-5. Epub 2008 Jan 10.
|
| 252 |
Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability.BMC Cancer. 2008 Nov 10;8:329. doi: 10.1186/1471-2407-8-329.
|
| 253 |
Down-regulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression.Clin Cancer Res. 1998 Aug;4(8):1857-63.
|
| 254 |
Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.Mol Cell Proteomics. 2011 Jan;10(1):M110.002998. doi: 10.1074/mcp.M110.002998. Epub 2010 Oct 11.
|
| 255 |
Knockdown of SLC39A7 inhibits cell growth and induces apoptosis in human colorectal cancer cells.Acta Biochim Biophys Sin (Shanghai). 2017 Oct 1;49(10):926-934. doi: 10.1093/abbs/gmx094.
|
| 256 |
NABC1 (BCAS1): alternative splicing and downregulation in colorectal tumors.Genomics. 2000 May 1;65(3):299-302. doi: 10.1006/geno.2000.6172.
|
| 257 |
Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT.Proc Natl Acad Sci U S A. 2006 May 9;103(19):7270-5. doi: 10.1073/pnas.0602365103. Epub 2006 May 2.
|
| 258 |
Pan-cancer analysis of the metabolic reaction network.Metab Eng. 2020 Jan;57:51-62. doi: 10.1016/j.ymben.2019.09.006. Epub 2019 Sep 14.
|
| 259 |
Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study.Carcinogenesis. 2007 Jul;28(7):1510-9. doi: 10.1093/carcin/bgm062. Epub 2007 Mar 26.
|
| 260 |
Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers.Oncogene. 2008 Dec 4;27(53):6729-37. doi: 10.1038/onc.2008.322. Epub 2008 Sep 15.
|
| 261 |
Alcohol and colorectal cancer: the role of alcohol dehydrogenase 1C polymorphism.Alcohol Clin Exp Res. 2009 Mar;33(3):551-6. doi: 10.1111/j.1530-0277.2008.00868.x. Epub 2008 Dec 19.
|
| 262 |
Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib.Mol Cancer Ther. 2009 Jul;8(7):1995-2006. doi: 10.1158/1535-7163.MCT-08-0987. Epub 2009 Jun 30.
|
| 263 |
Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography.World J Gastroenterol. 2006 Nov 7;12(41):6689-92. doi: 10.3748/wjg.v12.i41.6689.
|
| 264 |
Carboxylesterase 2 is downregulated in colorectal cancer following progression of the disease.Cancer Invest. 2008 Mar;26(2):178-81. doi: 10.1080/07357900701560786.
|
| 265 |
Relationship between genetic polymorphism of CYP1A1 at codon 462 (Ile462Val) in colorectal cancer.Int J Biol Markers. 2008 Jan-Mar;23(1):18-23. doi: 10.1177/172460080802300103.
|
| 266 |
Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas.BMC Cancer. 2007 Dec 19;7:228. doi: 10.1186/1471-2407-7-228.
|
| 267 |
Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study.Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):460-469. doi: 10.1158/1055-9965.EPI-19-0449. Epub 2019 Nov 18.
|
| 268 |
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis.Cancer Biother Radiopharm. 2009 Oct;24(5):565-72. doi: 10.1089/cbr.2009.0621.
|
| 269 |
N-acetyltransferase 1 in colon and rectal cancer cases from an industrialized area.J Toxicol Environ Health A. 2008;71(13-14):902-5. doi: 10.1080/15287390801988582.
|
| 270 |
Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.Asian Pac J Cancer Prev. 2007 Jul-Sep;8(3):438-44.
|
| 271 |
Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.Clin Cancer Res. 2005 Sep 15;11(18):6550-7. doi: 10.1158/1078-0432.CCR-05-0983.
|
| 272 |
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma.Hum Pathol. 2008 Jan;39(1):87-95. doi: 10.1016/j.humpath.2007.05.014. Epub 2007 Oct 18.
|
| 273 |
Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer.Mol Carcinog. 2009 Jul;48(7):642-7. doi: 10.1002/mc.20510.
|
| 274 |
Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J. 2006 Feb 15;394(Pt 1):317-24.
|
| 275 |
Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3098-107. doi: 10.1158/1055-9965.EPI-08-0341.
|
| 276 |
Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk.Carcinogenesis. 2004 Dec;25(12):2407-15. doi: 10.1093/carcin/bgh251. Epub 2004 Aug 19.
|
| 277 |
Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population.J Gastroenterol Hepatol. 2006 Jun;21(6):1036-41. doi: 10.1111/j.1440-1746.2005.04032.x.
|
| 278 |
Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival.Arch Toxicol. 2018 Jun;92(6):1991-1999. doi: 10.1007/s00204-018-2195-y. Epub 2018 May 16.
|
| 279 |
Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma.Cancer Sci. 2007 Jul;98(7):992-9. doi: 10.1111/j.1349-7006.2007.00488.x. Epub 2007 Apr 23.
|
| 280 |
Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.Int J Cancer. 2009 Mar 15;124(6):1258-62. doi: 10.1002/ijc.24023.
|
| 281 |
ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.Gene. 2004 Jul 7;336(1):59-71. doi: 10.1016/j.gene.2004.01.025.
|
| 282 |
POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance?.Anticancer Res. 2008 Mar-Apr;28(2B):1221-7.
|
| 283 |
Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.Genes Chromosomes Cancer. 2012 Dec;51(12):1133-43. doi: 10.1002/gcc.21998. Epub 2012 Aug 25.
|
| 284 |
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer.Br J Cancer. 2009 Feb 10;100(3):511-23. doi: 10.1038/sj.bjc.6604884. Epub 2009 Jan 20.
|
| 285 |
Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy.Cancer Res. 2005 Jun 1;65(11):4683-9. doi: 10.1158/0008-5472.CAN-04-3613.
|
| 286 |
Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX MouseModels.J Surg Res. 2019 Oct;242:145-150. doi: 10.1016/j.jss.2019.04.048. Epub 2019 May 9.
|
| 287 |
Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12.Int J Colorectal Dis. 2007 Jun;22(6):651-9. doi: 10.1007/s00384-006-0197-3. Epub 2006 Oct 18.
|
| 288 |
Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancer.Int J Cancer. 2003 Sep 10;106(4):505-509. doi: 10.1002/ijc.11264.
|
| 289 |
Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.Am J Pathol. 2016 Apr;186(4):1015-24. doi: 10.1016/j.ajpath.2015.11.012. Epub 2016 Feb 3.
|
| 290 |
Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumors.Int J Cancer. 1994 Jan 2;56(1):52-5. doi: 10.1002/ijc.2910560110.
|
| 291 |
EMX2 gene expression predicts liver metastasis and survival in colorectal cancer.BMC Cancer. 2017 Aug 22;17(1):555. doi: 10.1186/s12885-017-3556-2.
|
| 292 |
Alpha1,3 fucosyltransferase VII plays a role in colorectal carcinoma metastases by promoting the carbohydration of glycoprotein CD24.Oncol Rep. 2010 Jun;23(6):1609-17. doi: 10.3892/or_00000802.
|
| 293 |
GSTT2 promoter polymorphisms and colorectal cancer risk.BMC Cancer. 2007 Jan 25;7:16. doi: 10.1186/1471-2407-7-16.
|
| 294 |
Helicase-like transcription factor (Hltf) gene-deletion promotes oxidative phosphorylation (OXPHOS) in colorectal tumors of AOM/DSS-treated mice.PLoS One. 2019 Aug 28;14(8):e0221751. doi: 10.1371/journal.pone.0221751. eCollection 2019.
|
| 295 |
Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer.Cancer Res. 2006 Jan 15;66(2):763-9. doi: 10.1158/0008-5472.CAN-05-3771.
|
| 296 |
Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism.Int J Oncol. 2008 Jul;33(1):185-93.
|
| 297 |
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.Biomark Med. 2014;8(5):671-85. doi: 10.2217/bmm.13.151.
|
| 298 |
Expression of lysosome-associated membrane proteins in human colorectal neoplasms and inflammatory diseases.Am J Pathol. 2001 Aug;159(2):449-55. doi: 10.1016/S0002-9440(10)61716-6.
|
| 299 |
Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer.Oncogene. 2005 Apr 28;24(19):3100-9. doi: 10.1038/sj.onc.1208520.
|
| 300 |
mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma.Eur J Cancer Prev. 2009 Feb;18(1):40-5. doi: 10.1097/CEJ.0b013e32830c8d5a.
|
| 301 |
Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.Int J Oncol. 2007 Aug;31(2):333-8.
|
| 302 |
Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.Int J Mol Med. 2004 Mar;13(3):413-7.
|
| 303 |
Mutations in the human naked cuticle homolog NKD1 found in colorectal cancer alter Wnt/Dvl/beta-catenin signaling.PLoS One. 2009 Nov 24;4(11):e7982. doi: 10.1371/journal.pone.0007982.
|
| 304 |
The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells.Cancer Lett. 2011 Oct 28;309(2):137-44. doi: 10.1016/j.canlet.2011.05.025. Epub 2011 Jun 22.
|
| 305 |
Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability.Oncogene. 2002 Aug 1;21(33):5081-7. doi: 10.1038/sj.onc.1205703.
|
| 306 |
PPP1R3 gene (protein phosphatase 1) alterations in colorectal cancer and its relationship to metastasis.Oncol Rep. 2005 Jun;13(6):1223-7.
|
| 307 |
RAD50/MRE11/NBS1 proteins in relation to tumour development and prognosis in patients with microsatellite stable colorectal cancer.Histol Histopathol. 2008 Dec;23(12):1495-502. doi: 10.14670/HH-23.1495.
|
| 308 |
Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.Gastroenterology. 2009 Jan;136(1):206-16. doi: 10.1053/j.gastro.2008.09.063. Epub 2008 Oct 2.
|
| 309 |
Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells.Neoplasia. 2019 Jul;21(7):721-729. doi: 10.1016/j.neo.2019.04.009. Epub 2019 Jun 4.
|
| 310 |
Analysis of RIN1 gene expression in colorectal cancer.Oncol Rep. 2007 May;17(5):1171-5.
|
| 311 |
Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.Mol Nutr Food Res. 2008 Nov;52(11):1289-99. doi: 10.1002/mnfr.200700331.
|
| 312 |
Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers.Cancer Res. 2005 Jun 1;65(11):4607-13. doi: 10.1158/0008-5472.CAN-05-0165.
|
| 313 |
Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.Mol Cancer Res. 2008 Sep;6(9):1421-30. doi: 10.1158/1541-7786.MCR-07-2175.
|
| 314 |
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.Cell. 2002 Oct 18;111(2):251-63. doi: 10.1016/s0092-8674(02)01015-2.
|
| 315 |
Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.World J Gastroenterol. 2003 Aug;9(8):1729-33. doi: 10.3748/wjg.v9.i8.1729.
|
| 316 |
Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.Genes Chromosomes Cancer. 2004 Jul;40(3):247-60. doi: 10.1002/gcc.20039.
|
| 317 |
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.PLoS Genet. 2007 Sep;3(9):1709-23. doi: 10.1371/journal.pgen.0030157. Epub 2007 Jul 31.
|
| 318 |
The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.Am J Pathol. 2007 Nov;171(5):1509-19. doi: 10.2353/ajpath.2007.070331.
|
| 319 |
Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer.Oncology. 2005;68(2-3):246-55. doi: 10.1159/000086781. Epub 2005 Jul 7.
|
| 320 |
Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases.J Biol Chem. 2006 Dec 8;281(49):37828-35. doi: 10.1074/jbc.M602119200. Epub 2006 Oct 6.
|
| 321 |
Epigenetic silencing of LRRC3B in colorectal cancer.Scand J Gastroenterol. 2009;44(1):79-84. doi: 10.1080/00365520802400834.
|
| 322 |
Enhancement of TGF- signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer.Cancer Res. 2011 Oct 15;71(20):6438-49. doi: 10.1158/0008-5472.CAN-11-1645.
|
| 323 |
Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors.Endocr Relat Cancer. 2008 Mar;15(1):289-99. doi: 10.1677/ERC-07-0197.
|
| 324 |
Desmocollin switching in colorectal cancer.Br J Cancer. 2006 Nov 20;95(10):1367-70. doi: 10.1038/sj.bjc.6603453. Epub 2006 Oct 31.
|
| 325 |
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study.BMC Cancer. 2008 Feb 12;8:50. doi: 10.1186/1471-2407-8-50.
|
| 326 |
Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes.Cancer Biol Ther. 2006 Dec;5(12):1714-20. doi: 10.4161/cbt.5.12.3469. Epub 2006 Dec 30.
|
| 327 |
Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients.J Immunol. 2014 Jan 1;192(1):503-11. doi: 10.4049/jimmunol.1301951. Epub 2013 Dec 4.
|
| 328 |
Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.Genes Chromosomes Cancer. 2009 Apr;48(4):340-50. doi: 10.1002/gcc.20644.
|
| 329 |
Sequestration of 9-Hydroxystearic Acid in FAHFA (Fatty Acid Esters of Hydroxy Fatty Acids) as a Protective Mechanism for Colon Carcinoma Cells to Avoid Apoptotic Cell Death.Cancers (Basel). 2019 Apr 12;11(4):524. doi: 10.3390/cancers11040524.
|
| 330 |
Silencing of secreted frizzled-related protein genes in MSI colorectal carcinogenesis.Hepatogastroenterology. 2008 Jul-Aug;55(85):1265-8.
|
| 331 |
Expression of ST13 in colorectal cancer and adjacent normal tissues.World J Gastroenterol. 2005 Jan 21;11(3):336-9. doi: 10.3748/wjg.v11.i3.336.
|
| 332 |
Ileal Pouch-Anal Anastomosis for Dysplasia or Cancer Complicating Inflammatory Bowel Disease: Is Total Mesorectal Excision Always Mandatory? An Analysis of 36 Consecutive Patients.J Crohns Colitis. 2017 Aug 1;11(8):936-941. doi: 10.1093/ecco-jcc/jjx044.
|
| 333 |
Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket.J Biol Chem. 2005 Mar 4;280(9):8180-7. doi: 10.1074/jbc.M412211200. Epub 2004 Dec 20.
|
| 334 |
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.Nat Commun. 2019 May 14;10(1):2154. doi: 10.1038/s41467-019-09775-w.
|
| 335 |
ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.Int J Cancer. 2007 Oct 15;121(8):1710-6. doi: 10.1002/ijc.22882.
|
| 336 |
Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues.Am J Pathol. 2002 Nov;161(5):1657-67. doi: 10.1016/S0002-9440(10)64443-4.
|
| 337 |
CD97 overexpression in tumor cells at the invasion front in colorectal cancer (CC) is independently regulated of the canonical Wnt pathway.Mol Carcinog. 2006 Nov;45(11):881-6. doi: 10.1002/mc.20262.
|
| 338 |
GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.Mol Cancer Res. 2019 Nov;17(11):2196-2207. doi: 10.1158/1541-7786.MCR-19-0436. Epub 2019 Aug 23.
|
| 339 |
Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers.Oncogene. 2012 Mar 8;31(10):1242-53. doi: 10.1038/onc.2011.320. Epub 2011 Aug 1.
|
| 340 |
The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancer.Oncology. 2009;76(3):199-204. doi: 10.1159/000201572. Epub 2009 Feb 11.
|
| 341 |
Expression of 15-lipoxygenase-1 in human colorectal cancer.Cancer Res. 1999 Jan 15;59(2):360-6.
|
| 342 |
Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.J Proteome Res. 2008 Sep;7(9):3994-4003. doi: 10.1021/pr800271b. Epub 2008 Jul 24.
|
| 343 |
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice.Nat Genet. 2017 Feb;49(2):296-302. doi: 10.1038/ng.3744. Epub 2016 Dec 12.
|
| 344 |
Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.Carcinogenesis. 2007 Aug;28(8):1687-91. doi: 10.1093/carcin/bgm098. Epub 2007 Apr 21.
|
| 345 |
Clinical and prognostic significance of Arl4c expression in colorectal cancer.Cancer Biomark. 2016;16(2):253-7. doi: 10.3233/CBM-150562.
|
| 346 |
Functions of neutral ceramidase in the Golgi apparatus.J Lipid Res. 2018 Nov;59(11):2116-2125. doi: 10.1194/jlr.M088187. Epub 2018 Aug 28.
|
| 347 |
Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity.ACS Chem Biol. 2017 Apr 21;12(4):905-911. doi: 10.1021/acschembio.6b01158. Epub 2017 Mar 1.
|
| 348 |
Rad51C-ATXN7 fusion gene expression in colorectal tumors.Mol Cancer. 2016 Jun 13;15(1):47. doi: 10.1186/s12943-016-0527-1.
|
| 349 |
Colorectal cancer and genetic alterations in the Wnt pathway.Oncogene. 2006 Dec 4;25(57):7531-7. doi: 10.1038/sj.onc.1210059.
|
| 350 |
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability.Oncogene. 2006 Jan 5;25(1):139-46. doi: 10.1038/sj.onc.1209009.
|
| 351 |
Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4572-7. doi: 10.1073/pnas.0407983102. Epub 2005 Mar 8.
|
| 352 |
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.PLoS One. 2018 Apr 26;13(4):e0196245. doi: 10.1371/journal.pone.0196245. eCollection 2018.
|
| 353 |
G-quadruplex located in the 5'UTR of the BAG-1 mRNA affects both its cap-dependent and cap-independent translation through global secondary structure maintenance.Nucleic Acids Res. 2019 Nov 4;47(19):10247-10266. doi: 10.1093/nar/gkz777.
|
| 354 |
Class III -tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response.Anticancer Res. 2019 Feb;39(2):655-662. doi: 10.21873/anticanres.13160.
|
| 355 |
BLM heterozygosity and the risk of colorectal cancer.Science. 2002 Sep 20;297(5589):2013. doi: 10.1126/science.1074399.
|
| 356 |
Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development.Genes Chromosomes Cancer. 2008 Jun;47(6):449-60. doi: 10.1002/gcc.20552.
|
| 357 |
Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas.Oncotarget. 2017 Oct 9;8(58):98623-98634. doi: 10.18632/oncotarget.21697. eCollection 2017 Nov 17.
|
| 358 |
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.Cancer Res. 2008 Jun 1;68(11):4123-32. doi: 10.1158/0008-5472.CAN-08-0325.
|
| 359 |
Aneuploidy is associated with TP53 expression but not with BRCA1 or TERT expression in sporadic colorectal cancer.Anticancer Res. 2009 Nov;29(11):4381-7.
|
| 360 |
Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.J Gastroenterol Hepatol. 2007 Dec;22(12):2298-302. doi: 10.1111/j.1440-1746.2007.04843.x. Epub 2007 Jun 7.
|
| 361 |
MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation.Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5481-90. doi: 10.1073/pnas.1610994113. Epub 2016 Aug 26.
|
| 362 |
CDC5L Promotes hTERT Expression and Colorectal Tumor Growth.Cell Physiol Biochem. 2017;41(6):2475-2488. doi: 10.1159/000475916. Epub 2017 May 4.
|
| 363 |
Determination of Cadherin-17 in Tumor Tissues of Different Metastatic Grade Using a Single Incubation-Step Amperometric Immunosensor.Anal Chem. 2018 Sep 18;90(18):11161-11167. doi: 10.1021/acs.analchem.8b03506. Epub 2018 Sep 6.
|
| 364 |
A del T poly T (8) mutation in the 3' untranslated region (UTR) of the CDK2-AP1 gene is functionally significant causing decreased mRNA stability resulting in decreased CDK2-AP1 expression in human microsatellite unstable (MSI) colorectal cancer (CRC).Surgery. 2007 Aug;142(2):222-7. doi: 10.1016/j.surg.2007.04.002.
|
| 365 |
Cdx1 homeobox gene during human colon cancer progression.Oncogene. 2003 Sep 11;22(39):7913-21. doi: 10.1038/sj.onc.1206756.
|
| 366 |
Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay.Surgery. 2006 Apr;139(4):556-62. doi: 10.1016/j.surg.2005.09.025.
|
| 367 |
Early insights into the function of KIAA1199, a markedly overexpressed protein in human colorectal tumors.PLoS One. 2013 Jul 23;8(7):e69473. doi: 10.1371/journal.pone.0069473. Print 2013.
|
| 368 |
Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer.Cancer Res. 2003 Jul 1;63(13):3511-6.
|
| 369 |
Coding region polymorphisms in the CHFR mitotic stress checkpoint gene are associated with colorectal cancer risk.Cancer Lett. 2008 Feb 18;260(1-2):170-9. doi: 10.1016/j.canlet.2007.10.036.
|
| 370 |
Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells.Oncotarget. 2018 Jun 12;9(45):27835-27850. doi: 10.18632/oncotarget.25600. eCollection 2018 Jun 12.
|
| 371 |
Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells.Cancer Res. 2018 Jun 1;78(11):2925-2938. doi: 10.1158/0008-5472.CAN-17-1869. Epub 2018 Mar 6.
|
| 372 |
Claudins upregulation in human colorectal cancer.FEBS Lett. 2005 Nov 7;579(27):6179-85. doi: 10.1016/j.febslet.2005.09.091. Epub 2005 Oct 13.
|
| 373 |
CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.Cancer Res. 2009 Jun 15;69(12):5194-201. doi: 10.1158/0008-5472.CAN-08-3694. Epub 2009 Jun 9.
|
| 374 |
Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.Am J Pathol. 2006 Mar;168(3):856-65. doi: 10.2353/ajpath.2006.050384.
|
| 375 |
Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.PLoS One. 2013;8(3):e58731. doi: 10.1371/journal.pone.0058731. Epub 2013 Mar 7.
|
| 376 |
Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.Pathol Res Pract. 2017 Dec;213(12):1568-1574. doi: 10.1016/j.prp.2017.06.007. Epub 2017 Jun 6.
|
| 377 |
Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.Cancer Res. 2002 Jun 1;62(11):3322-6.
|
| 378 |
Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.Oncol Rep. 2009 Jan;21(1):57-63.
|
| 379 |
pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1).PLoS One. 2014 Jan 22;9(1):e85796. doi: 10.1371/journal.pone.0085796. eCollection 2014.
|
| 380 |
Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients.Clin Cancer Res. 2008 Apr 15;14(8):2276-84. doi: 10.1158/1078-0432.CCR-07-4045.
|
| 381 |
Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence.Histopathology. 2008 Apr;52(5):569-77. doi: 10.1111/j.1365-2559.2008.02996.x.
|
| 382 |
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell. 2008 Jun;13(6):529-41. doi: 10.1016/j.ccr.2008.04.019.
|
| 383 |
Genome-wide association study of colorectal cancer identifies six new susceptibility loci.Nat Commun. 2015 Jul 7;6:7138. doi: 10.1038/ncomms8138.
|
| 384 |
Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.Gastroenterology. 2007 Dec;133(6):1849-57. doi: 10.1053/j.gastro.2007.08.074. Epub 2007 Sep 5.
|
| 385 |
Non-thermal plasma induces immunogenic cell death in vivo in murine CT26 colorectal tumors.Oncoimmunology. 2018 Jul 26;7(9):e1484978. doi: 10.1080/2162402X.2018.1484978. eCollection 2018.
|
| 386 |
Real-time PCR quantification of human DKC1 expression in colorectal cancer.Acta Oncol. 2008;47(8):1598-9. doi: 10.1080/02841860801898616.
|
| 387 |
DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer.Cancer Sci. 2009 Oct;100(10):1923-30. doi: 10.1111/j.1349-7006.2009.01272.x. Epub 2009 Jul 2.
|
| 388 |
Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.Int J Mol Med. 2008 Jan;21(1):19-31.
|
| 389 |
Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer.PLoS One. 2014 Jan 17;9(1):e85750. doi: 10.1371/journal.pone.0085750. eCollection 2014.
|
| 390 |
Dual-specificity phosphatase 6 deletion protects the colonic epithelium against inflammation and promotes both proliferation and tumorigenesis.J Cell Physiol. 2019 May;234(5):6731-6745. doi: 10.1002/jcp.27420. Epub 2018 Oct 1.
|
| 391 |
Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers.Clin Cancer Res. 2006 Jun 15;12(12):3713-5. doi: 10.1158/1078-0432.CCR-06-0800.
|
| 392 |
Functional impact of colorectal cancer-associated mutations in the transcription factor E2F4.Int J Oncol. 2013 Dec;43(6):2015-22. doi: 10.3892/ijo.2013.2131. Epub 2013 Oct 8.
|
| 393 |
Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3.Oncogene. 2010 Feb 4;29(5):647-61. doi: 10.1038/onc.2009.369. Epub 2009 Nov 16.
|
| 394 |
Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage.Mucosal Immunol. 2019 Sep;12(5):1164-1173. doi: 10.1038/s41385-019-0184-y. Epub 2019 Jul 5.
|
| 395 |
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.Nat Genet. 2008 May;40(5):623-30. doi: 10.1038/ng.111. Epub 2008 Mar 30.
|
| 396 |
Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.J Exp Clin Cancer Res. 2019 May 14;38(1):196. doi: 10.1186/s13046-019-1178-z.
|
| 397 |
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.Carcinogenesis. 2016 Jan;37(1):87-95. doi: 10.1093/carcin/bgv161. Epub 2015 Nov 19.
|
| 398 |
Correlation between expression and differentiation of endocan in colorectal cancer.World J Gastroenterol. 2008 Jul 28;14(28):4562-8. doi: 10.3748/wjg.14.4562.
|
| 399 |
Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.Carcinogenesis. 2005 May;26(5):892-9. doi: 10.1093/carcin/bgi029. Epub 2005 Feb 3.
|
| 400 |
Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.Nat Commun. 2016 May 5;7:11478. doi: 10.1038/ncomms11478.
|
| 401 |
MLH3 and EXO1 alterations in familial colorectal cancer patients not fulfilling Amsterdam criteria.Cancer Genet Cytogenet. 2007 Jul 15;176(2):172-4. doi: 10.1016/j.cancergencyto.2007.04.011.
|
| 402 |
EYA1 promotes tumor angiogenesis by activating the PI3K pathway in colorectal cancer.Exp Cell Res. 2018 Jun 1;367(1):37-46. doi: 10.1016/j.yexcr.2018.02.028. Epub 2018 Feb 27.
|
| 403 |
Fatty acid binding protein 6 is overexpressed in colorectal cancer.Clin Cancer Res. 2006 Sep 1;12(17):5090-5. doi: 10.1158/1078-0432.CCR-05-2045.
|
| 404 |
Overexpression of Rad51C splice variants in colorectal tumors.Oncotarget. 2015 Apr 20;6(11):8777-87. doi: 10.18632/oncotarget.3209.
|
| 405 |
Mutations of the Birt-Hogg-Dub (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability.J Med Genet. 2003 May;40(5):364-7. doi: 10.1136/jmg.40.5.364.
|
| 406 |
Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor.World J Gastroenterol. 2006 Nov 28;12(44):7113-7. doi: 10.3748/wjg.v12.i44.7113.
|
| 407 |
PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors.Oncotarget. 2016 Apr 5;7(14):18940-52. doi: 10.18632/oncotarget.8005.
|
| 408 |
Decreased expression of alpha-L-fucosidase gene FUCA1 in human colorectal tumors.Int J Mol Sci. 2013 Aug 19;14(8):16986-98. doi: 10.3390/ijms140816986.
|
| 409 |
Interaction of Mat-8 (FXYD-3) with Na+/K+-ATPase in colorectal cancer cells.Biol Pharm Bull. 2007 Apr;30(4):648-54. doi: 10.1248/bpb.30.648.
|
| 410 |
Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.Ann Surg Oncol. 2014 Dec;21 Suppl 4:S743-9. doi: 10.1245/s10434-014-3889-x. Epub 2014 Jul 17.
|
| 411 |
Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer.Oncology. 2004;67(3-4):271-6. doi: 10.1159/000081328.
|
| 412 |
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy.Int J Cancer. 2008 Nov 1;123(9):2120-9. doi: 10.1002/ijc.23764.
|
| 413 |
C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells.Oncogene. 2006 Jun 1;25(23):3267-76. doi: 10.1038/sj.onc.1209350. Epub 2006 Jan 16.
|
| 414 |
Clinical significance of growth differentiation factor 11 in colorectal cancer.Int J Oncol. 2007 Nov;31(5):1097-101.
|
| 415 |
Molecular cloning and characterization of human GIPC2, a novel gene homologous to human GIPC1 and Xenopus Kermit.Int J Oncol. 2002 Mar;20(3):571-6.
|
| 416 |
Identification and distribution of thioredoxin-like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer.Proteomics. 2008 Jun;8(11):2220-9. doi: 10.1002/pmic.200700770.
|
| 417 |
Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.Int J Cancer. 2017 Jun 15;140(12):2728-2733. doi: 10.1002/ijc.30687. Epub 2017 Mar 28.
|
| 418 |
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.Nat Genet. 2012 May 27;44(7):770-6. doi: 10.1038/ng.2293.
|
| 419 |
Chemopreventive Action by Ethanol-extracted Brazilian Green Propolis on Post-initiation Phase of Inflammation-associated Rat Colon Tumorigenesis.In Vivo. 2017 Mar-Apr;31(2):187-197. doi: 10.21873/invivo.11044.
|
| 420 |
Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer.Genes Nutr. 2007 Nov;2(2):225-32. doi: 10.1007/s12263-007-0052-3. Epub 2007 Oct 13.
|
| 421 |
The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2328-37. doi: 10.1158/1055-9965.EPI-14-0440. Epub 2014 Oct 10.
|
| 422 |
A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples.Clin Chem Lab Med. 2005;43(7):707-14. doi: 10.1515/CCLM.2005.120.
|
| 423 |
Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer.Cell Death Dis. 2014 Jul 17;5(7):e1324. doi: 10.1038/cddis.2014.283.
|
| 424 |
A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer.Oncol Rep. 2006 Apr;15(4):919-26.
|
| 425 |
Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis.Front Immunol. 2019 Jul 15;10:1573. doi: 10.3389/fimmu.2019.01573. eCollection 2019.
|
| 426 |
Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells.Clin Exp Metastasis. 2007;24(3):201-9. doi: 10.1007/s10585-007-9069-7. Epub 2007 May 9.
|
| 427 |
Genome-wide significant risk associations for mucinous ovarian carcinoma.Nat Genet. 2015 Aug;47(8):888-97. doi: 10.1038/ng.3336. Epub 2015 Jun 15.
|
| 428 |
Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer.Nat Genet. 2013 Feb;45(2):191-6. doi: 10.1038/ng.2505. Epub 2012 Dec 23.
|
| 429 |
Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracilbased chemotherapy.Gastroenterology. 2014 Feb;146(2):401-11.e1. doi: 10.1053/j.gastro.2013.10.054.
|
| 430 |
Influences of the interferon induced transmembrane protein 1 on the proliferation, invasion, and metastasis of the colorectal cancer SW480 cell lines.Chin Med J (Engl). 2012 Feb;125(3):517-22.
|
| 431 |
Anti-EpCAM monoclonal antibody (MAb17-1A) based treatment combined with alpha-interferon, 5-fluorouracil and granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.Int J Oncol. 2004 Sep;25(3):703-11.
|
| 432 |
Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. Clin Cancer Res. 2009 Mar 1;15(5):1519-26. doi: 10.1158/1078-0432.CCR-08-1778. Epub 2009 Feb 17.
|
| 433 |
ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.Oncotarget. 2016 Nov 29;7(48):79017-79031. doi: 10.18632/oncotarget.12984.
|
| 434 |
Histone Demethylase JMJD2D Interacts With -Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.Gastroenterology. 2019 Mar;156(4):1112-1126. doi: 10.1053/j.gastro.2018.11.036. Epub 2018 Nov 23.
|
| 435 |
Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer.Br J Cancer. 2008 Jun 3;98(11):1824-9. doi: 10.1038/sj.bjc.6604379. Epub 2008 May 27.
|
| 436 |
Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.World J Gastroenterol. 2007 Aug 7;13(29):3932-8. doi: 10.3748/wjg.v13.i29.3932.
|
| 437 |
Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.Cancer Lett. 2014 Dec 1;355(1):25-33. doi: 10.1016/j.canlet.2014.09.022. Epub 2014 Sep 19.
|
| 438 |
Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients.Cancer. 1997 May 1;79(9):1664-70.
|
| 439 |
The leukocyte protein L-plastin induces proliferation, invasion and loss of E-cadherin expression in colon cancer cells.Int J Cancer. 2006 Apr 15;118(8):2098-104. doi: 10.1002/ijc.21593.
|
| 440 |
Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.Oncol Rep. 2004 Aug;12(2):275-80.
|
| 441 |
Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.Hum Mol Genet. 2014 Sep 1;23(17):4729-37. doi: 10.1093/hmg/ddu177. Epub 2014 Apr 15.
|
| 442 |
High frequency of LMAN1 abnormalities in colorectal tumors with microsatellite instability.Cancer Res. 2009 Jan 1;69(1):292-9. doi: 10.1158/0008-5472.CAN-08-3314.
|
| 443 |
Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients.Clin Cancer Res. 2007 Nov 1;13(21):6351-8. doi: 10.1158/1078-0432.CCR-07-0882.
|
| 444 |
Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells.Cancer Res. 2010 Jan 15;70(2):560-7. doi: 10.1158/0008-5472.CAN-09-3513. Epub 2010 Jan 12.
|
| 445 |
C4.4A as a candidate marker in the diagnosis of colorectal cancer.Br J Cancer. 2007 Oct 22;97(8):1146-56. doi: 10.1038/sj.bjc.6604012. Epub 2007 Oct 2.
|
| 446 |
MACC1 is related to colorectal cancer initiation and early-stage invasive growth.Am J Clin Pathol. 2013 Nov;140(5):701-7. doi: 10.1309/AJCPRH1H5RWWSXRB.
|
| 447 |
Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer.Int J Cancer. 2007 Jan 1;120(1):207-11. doi: 10.1002/ijc.22155.
|
| 448 |
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.J Transl Med. 2008 Mar 17;6:13. doi: 10.1186/1479-5876-6-13.
|
| 449 |
Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers.Dis Markers. 2014;2014:798170. doi: 10.1155/2014/798170. Epub 2014 Apr 30.
|
| 450 |
Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis.Oncotarget. 2015 Dec 15;6(40):42892-904. doi: 10.18632/oncotarget.5740.
|
| 451 |
Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC.Mol Ther Nucleic Acids. 2017 Sep 15;8:36-45. doi: 10.1016/j.omtn.2017.05.010. Epub 2017 Jun 1.
|
| 452 |
Activation of human meprin-alpha in a cell culture model of colorectal cancer is triggered by the plasminogen-activating system.J Biol Chem. 2002 Oct 25;277(43):40650-8. doi: 10.1074/jbc.M206203200. Epub 2002 Aug 19.
|
| 453 |
Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma.Int J Cancer. 2005 Jun 10;115(2):256-62. doi: 10.1002/ijc.20883.
|
| 454 |
Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.Eur Arch Otorhinolaryngol. 1991;248(5):279-85. doi: 10.1007/BF00176755.
|
| 455 |
Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.Cancer Genet. 2014 Oct-Dec;207(10-12):495-502. doi: 10.1016/j.cancergen.2014.10.002. Epub 2014 Oct 13.
|
| 456 |
Murine MTHFD1-synthetase deficiency, a model for the human MTHFD1 R653Q polymorphism, decreases growth of colorectal tumors.Mol Carcinog. 2017 Mar;56(3):1030-1040. doi: 10.1002/mc.22568. Epub 2016 Nov 1.
|
| 457 |
MUC13 promotes the development of colitis-associated colorectal tumors via -catenin activity.Oncogene. 2019 Nov;38(48):7294-7310. doi: 10.1038/s41388-019-0951-y. Epub 2019 Aug 19.
|
| 458 |
Gamma-secretase inhibitor, apotential target therapy for MUC2-positive colorectal carcinoma.Neoplasma. 2011;58(4):343-7. doi: 10.4149/neo_2011_04_343.
|
| 459 |
Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis.Cancer Sci. 2008 Oct;99(10):1977-83. doi: 10.1111/j.1349-7006.2008.00954.x.
|
| 460 |
Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.Clin Cancer Res. 2004 Mar 1;10(5):1758-63. doi: 10.1158/1078-0432.ccr-0779-3.
|
| 461 |
Unregulated smooth-muscle myosin in human intestinal neoplasia.Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5513-8. doi: 10.1073/pnas.0801213105. Epub 2008 Apr 7.
|
| 462 |
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.Nat Genet. 2010 Nov;42(11):973-7. doi: 10.1038/ng.670. Epub 2010 Oct 24.
|
| 463 |
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.Gastroenterology. 2013 Apr;144(4):799-807.e24. doi: 10.1053/j.gastro.2012.12.020. Epub 2012 Dec 22.
|
| 464 |
Aberrant cytoplasmic localization of N-CoR in colorectal tumors.Cell Cycle. 2007 Jul 15;6(14):1748-52. doi: 10.4161/cc.6.14.4429. Epub 2007 May 10.
|
| 465 |
A novel signaling pathway regulates colon cancer angiogenesis through Norrin.Sci Rep. 2014 Jul 9;4:5630. doi: 10.1038/srep05630.
|
| 466 |
Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers.Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3443-8. doi: 10.1073/pnas.0712384105. Epub 2008 Feb 25.
|
| 467 |
Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.Cancer Lett. 2018 Sep 1;431:43-53. doi: 10.1016/j.canlet.2018.05.032. Epub 2018 May 25.
|
| 468 |
The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.Mol Cancer Res. 2008 Sep;6(9):1461-8. doi: 10.1158/1541-7786.MCR-07-2094.
|
| 469 |
Clinical significance of chicken ovalbumin upstream promoter-transcription factor II expression in human colorectal cancer.Oncol Rep. 2009 Jan;21(1):101-6.
|
| 470 |
Identification and characterization of ErbB-3-binding protein-1 as a target for immunotherapy.J Immunol. 2007 Aug 1;179(3):2005-12. doi: 10.4049/jimmunol.179.3.2005.
|
| 471 |
Zinc finger protein 278, a potential oncogene in human colorectal cancer.Acta Biochim Biophys Sin (Shanghai). 2008 Apr;40(4):289-96. doi: 10.1111/j.1745-7270.2008.00405.x.
|
| 472 |
Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer.J Cancer Res Clin Oncol. 2013 Mar;139(3):485-90. doi: 10.1007/s00432-012-1353-5. Epub 2012 Nov 22.
|
| 473 |
High Expression and Clinical Significance of Elafin in Colorectal Cancer.Gastroenterol Res Pract. 2019 Jun 9;2019:4946824. doi: 10.1155/2019/4946824. eCollection 2019.
|
| 474 |
GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12.Carcinogenesis. 2018 May 3;39(5):652-660. doi: 10.1093/carcin/bgy026.
|
| 475 |
Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.Gastroenterology. 2018 Sep;155(3):844-851. doi: 10.1053/j.gastro.2018.05.020. Epub 2018 Jul 29.
|
| 476 |
Down-regulation of drs mRNA in colorectal neoplasms.Jpn J Cancer Res. 2002 Aug;93(8):888-93. doi: 10.1111/j.1349-7006.2002.tb01334.x.
|
| 477 |
BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.Oncotarget. 2016 Feb 23;7(8):9188-221. doi: 10.18632/oncotarget.6942.
|
| 478 |
PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.Oncol Rep. 2004 Mar;11(3):655-9.
|
| 479 |
Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products.FEBS Lett. 1997 Apr 14;406(3):234-42. doi: 10.1016/s0014-5793(97)00208-1.
|
| 480 |
PRR5 encodes a conserved proline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas.Genomics. 2005 Mar;85(3):338-51. doi: 10.1016/j.ygeno.2004.11.002.
|
| 481 |
The proteasome subunit PSMA7 located on the 20q13 amplicon is overexpressed and associated with liver metastasis in colorectal cancer.Oncol Rep. 2008 Feb;19(2):441-6.
|
| 482 |
Downregulation of PTPRH (Sap-1) in colorectal tumors.Int J Oncol. 2017 Sep;51(3):841-850. doi: 10.3892/ijo.2017.4068. Epub 2017 Jul 5.
|
| 483 |
The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer. Chem Biol Interact. 2014 Sep 5;220:41-50. doi: 10.1016/j.cbi.2014.06.006. Epub 2014 Jun 12.
|
| 484 |
Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.Oncotarget. 2015 Apr 20;6(11):8698-708. doi: 10.18632/oncotarget.3537.
|
| 485 |
Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.Cancer Biol Ther. 2007 Nov;6(11):1710-6. doi: 10.4161/cbt.6.11.4829. Epub 2007 Aug 3.
|
| 486 |
Single nucleotide polymorphism in the RAD18 gene and risk of colorectal cancer in the Japanese population.Oncol Rep. 2007 Nov;18(5):1171-5.
|
| 487 |
Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer.Oncogene. 2014 Feb 13;33(7):814-22. doi: 10.1038/onc.2013.17. Epub 2013 Feb 18.
|
| 488 |
Crystal structure of the rac activator, Asef, reveals its autoinhibitory mechanism.J Biol Chem. 2007 Feb 16;282(7):4238-4242. doi: 10.1074/jbc.C600234200. Epub 2006 Dec 26.
|
| 489 |
Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.World J Gastroenterol. 2008 May 21;14(19):3074-80. doi: 10.3748/wjg.14.3074.
|
| 490 |
Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.Int J Cancer. 2007 Jan 1;120(1):7-12. doi: 10.1002/ijc.22276.
|
| 491 |
Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.BMC Cancer. 2010 Oct 22;10:577. doi: 10.1186/1471-2407-10-577.
|
| 492 |
Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumors.PLoS One. 2009 Nov 2;4(11):e7715. doi: 10.1371/journal.pone.0007715.
|
| 493 |
Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.Oncogene. 2008 Jul 31;27(33):4544-56. doi: 10.1038/onc.2008.97. Epub 2008 Apr 21.
|
| 494 |
REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis.Int J Cancer. 2008 Jul 15;123(2):409-413. doi: 10.1002/ijc.23466.
|
| 495 |
RFX-B, a MHC class II transcription factor, suppressed in human colorectal adenocarcinomas.Int J Mol Med. 2002 Mar;9(3):213-6.
|
| 496 |
Primary colorectal tumors fail to express the proapoptotic mediator PTAG and its reexpression augments drug-induced apoptosis.Genes Chromosomes Cancer. 2007 Feb;46(2):202-12. doi: 10.1002/gcc.20401.
|
| 497 |
Epithelial RNase H2 Maintains Genome Integrity and Prevents Intestinal Tumorigenesis in Mice.Gastroenterology. 2019 Jan;156(1):145-159.e19. doi: 10.1053/j.gastro.2018.09.047. Epub 2018 Sep 28.
|
| 498 |
The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/-catenin pathway via ubiquitination of Axin1.Biochem Biophys Res Commun. 2018 Sep 5;503(2):991-997. doi: 10.1016/j.bbrc.2018.06.107. Epub 2018 Jun 25.
|
| 499 |
Mutations of rabphillin-3A-like gene in colorectal cancers.Oncol Rep. 2002 Nov-Dec;9(6):1189-92.
|
| 500 |
Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues.Int J Colorectal Dis. 2008 Jul;23(7):675-82. doi: 10.1007/s00384-008-0464-6. Epub 2008 Mar 14.
|
| 501 |
Expression of tumor rejection antigens in colorectal carcinomas.Cancer. 2002 Mar 15;94(6):1636-41. doi: 10.1002/cncr.10421.
|
| 502 |
Adenovirus-mediated expression of spermidine/spermine N1-acetyltransferase gene induces S-phase arrest in human colorectal cancer cells.Oncol Rep. 2008 Nov;20(5):1229-35.
|
| 503 |
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk.Nat Genet. 2008 Jan;40(1):26-8. doi: 10.1038/ng.2007.41. Epub 2007 Dec 16.
|
| 504 |
Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis.Int J Oncol. 2006 Feb;28(2):527-33. doi: 10.3892/ijo.28.2.527.
|
| 505 |
Impaired expression of a human septin family gene Bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo.Cancer Gene Ther. 2002 Jun;9(6):483-8. doi: 10.1038/sj.cgt.7700460.
|
| 506 |
Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.PLoS One. 2008;3(11):e3759. doi: 10.1371/journal.pone.0003759. Epub 2008 Nov 19.
|
| 507 |
The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.Mol Cancer. 2010 Oct 13;9:271. doi: 10.1186/1476-4598-9-271.
|
| 508 |
Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.Oncol Rep. 2007 Dec;18(6):1451-6.
|
| 509 |
TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis.Cell Oncol. 2009;31(1):41-51. doi: 10.3233/clo-2009-0460.
|
| 510 |
SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells.PLoS Genet. 2017 Nov 20;13(11):e1007109. doi: 10.1371/journal.pgen.1007109. eCollection 2017 Nov.
|
| 511 |
Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res. 2008 Apr 15;68(8):2764-72. doi: 10.1158/0008-5472.CAN-07-6349.
|
| 512 |
Prognostic value of SPARCL1 in patients with colorectal cancer.Oncol Lett. 2018 Feb;15(2):1429-1434. doi: 10.3892/ol.2017.7511. Epub 2017 Dec 5.
|
| 513 |
Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42.Oncogene. 2007 Dec 6;26(55):7620-267. doi: 10.1038/sj.onc.1210574. Epub 2007 Jun 18.
|
| 514 |
Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas.Histol Histopathol. 2003 Oct;18(4):1181-8. doi: 10.14670/HH-18.1181.
|
| 515 |
Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.Int J Mol Med. 2002 May;9(5):485-8.
|
| 516 |
Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors.Int J Cancer. 2005 Feb 10;113(4):611-8. doi: 10.1002/ijc.20526.
|
| 517 |
Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growth.Cancer Res. 2005 Jan 1;65(1):195-202.
|
| 518 |
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009 Jun 1;69(11):4691-9. doi: 10.1158/0008-5472.CAN-08-0142. Epub 2009 May 12.
|
| 519 |
TGF induced factor homeobox 1 promotes colorectal cancer development through activating Wnt/-catenin signaling.Oncotarget. 2017 Jul 26;8(41):70214-70225. doi: 10.18632/oncotarget.19603. eCollection 2017 Sep 19.
|
| 520 |
Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer.Bull Exp Biol Med. 2007 Apr;143(4):459-62. doi: 10.1007/s10517-007-0156-1.
|
| 521 |
Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1.Cancer Sci. 2003 Feb;94(2):166-72. doi: 10.1111/j.1349-7006.2003.tb01414.x.
|
| 522 |
Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.World J Gastroenterol. 2007 Feb 14;13(6):950-4. doi: 10.3748/wjg.v13.i6.950.
|
| 523 |
Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy.Oncogenesis. 2017 Sep 18;6(9):e378. doi: 10.1038/oncsis.2017.77.
|
| 524 |
-catenin regulates NF-B activity via TNFRSF19 in colorectal cancer cells.Int J Cancer. 2014 Oct 15;135(8):1800-11. doi: 10.1002/ijc.28839. Epub 2014 Apr 1.
|
| 525 |
Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.Int J Cancer. 2008 Jun 1;122(11):2454-61. doi: 10.1002/ijc.23417.
|
| 526 |
Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.Dis Colon Rectum. 2006 May;49(5):588-94. doi: 10.1007/s10350-006-0515-4.
|
| 527 |
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.Oncotarget. 2017 Mar 28;8(13):21229-21240. doi: 10.18632/oncotarget.15070.
|
| 528 |
TRIB3 Interacts With -Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.Gastroenterology. 2019 Feb;156(3):708-721.e15. doi: 10.1053/j.gastro.2018.10.031. Epub 2018 Oct 24.
|
| 529 |
TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.
|
| 530 |
The role of trophinin, an adhesion molecule unique to human trophoblasts, in progression of colorectal cancer.Int J Cancer. 2007 Sep 1;121(5):1072-8. doi: 10.1002/ijc.22821.
|
| 531 |
ALEX1 suppresses colony formation ability of human colorectal carcinoma cell lines.Cancer Sci. 2012 Jul;103(7):1267-71. doi: 10.1111/j.1349-7006.2012.02300.x. Epub 2012 May 17.
|
| 532 |
Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer.Nat Genet. 2018 Oct;50(10):1375-1380. doi: 10.1038/s41588-018-0211-z. Epub 2018 Sep 17.
|
| 533 |
Stimulation of -catenin and colon cancer cell growth by the KDM4B histone demethylase.Int J Oncol. 2014 Apr;44(4):1341-8. doi: 10.3892/ijo.2014.2279. Epub 2014 Jan 27.
|
| 534 |
Brush border myosin Ia has tumor suppressor activity in the intestine.Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1530-5. doi: 10.1073/pnas.1108411109. Epub 2012 Jan 18.
|
| 535 |
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.Gastroenterology. 2014 May;146(5):1301-12.e1-10. doi: 10.1053/j.gastro.2014.02.003. Epub 2014 Feb 11.
|
| 536 |
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet. 2013 Feb;45(2):136-44. doi: 10.1038/ng.2503. Epub 2012 Dec 23.
|
| 537 |
The interaction of Hemin and Sestrin2 modulates oxidative stress and colon tumor growth. Toxicol Appl Pharmacol. 2019 Jul 1;374:77-85.
|
| 538 |
Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype.Mol Carcinog. 2012 Sep;51(9):746-53. doi: 10.1002/mc.20843. Epub 2011 Aug 30.
|
| 539 |
Genome-wide screening for methylation-silenced genes in colorectal cancer.Int J Oncol. 2012 Aug;41(2):490-6. doi: 10.3892/ijo.2012.1500. Epub 2012 May 30.
|
|
|
|
|
|
|
